Paclitaxel - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

paclitaxel sz paclitaxel 30mg/5ml solution for injection vial

alphapharm pty ltd - paclitaxel -

United States - English - NLM (National Library of Medicine)

paclitaxel injection, solution

actavis pharma, inc. - paclitaxel (unii: p88xt4is4d) (paclitaxel - unii:p88xt4is4d) - paclitaxel injection, usp is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary. as first-line therapy, paclitaxel injection, usp is indicated in combination with cisplatin. paclitaxel injection, usp is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. in the clinical trial, there was an overall favorable effect on disease-free and overall survival in the total population of patients with receptor-positive and receptor-negative tumors, but the benefit has been specifically demonstrated by available data (median follow-up 30 months) only in the patients with estrogen and progesterone receptor-negative tumors (see clinical studies, breast carcinoma). paclitaxel injection, usp is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. prior therapy should have included a

Australia - English - Department of Health (Therapeutic Goods Administration)

paclitaxel apotex paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial

arrotex pharmaceuticals pty ltd - paclitaxel, quantity: 100 mg - injection, powder for - excipient ingredients: albumin; sodium octanoate; n-acetyltryptophan - metastatic breast cancer albumin-bound paclitaxel is indicated for the treatment of metastatic carcinoma of the breast after failure of anthracycline therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

paclitaxel 6 mg/ml concentrate for solution for infusion

cipla (eu) limited - paclitaxel - concentrate for solution for infusion - 6 milligram(s)/millilitre - taxanes - plant alkaloids and other natural products, taxanes - it is indicated for the treatment of patients with carcinoma. see spc for all therapeutic indications